Witold Rybka

Witold Rybka, MD, FRCPC, is a Professor in the Department of Medicine, Division of Hematology and Oncology at the Penn State College of Medicine, affiliated with the Penn State Cancer Institute's Next-Generation Therapies program. His work focuses on hematologic malignancies, stem cell transplantation, and immunotherapy.

Research Interests: Rybka's research spans acute myeloid leukemia (AML), allogeneic hematopoietic stem cell transplantation (allo-HSCT), and graft-versus-host disease (GvHD). He investigates cyclophosphamide's role in transplantation, T-cell dynamics in leukemia, and chimerism testing for relapse prediction. His clinical trials focus on chemotherapy regimens for leukemia and breast cancer.

Scientific Awards:

• Fellow of the Royal College of Physicians of Canada (FRCPC)

Collaborations: He collaborates with institutions globally on clinical trials and transplantation research, particularly with teams in Japan (Mineishi, Minagawa) and Italy (Paules).